These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3934648)

  • 21. Effects of thyrotropin-releasing hormone on myocardial adrenoceptors and dopaminergic receptors following hemorrhagic shock in the rat.
    Liu LM; Chen HS; Hu DY; Lu RQ; Li TX
    Shock; 1995 Jun; 3(6):430-3. PubMed ID: 7656067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats.
    Karasawa A; Rochester JA; Lefer AM
    Circ Shock; 1992 Feb; 36(2):154-61. PubMed ID: 1582007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyrotropin releasing hormone in hypovolemia: a hemodynamic evaluation in the rat.
    Sirén AL; Powell E; Feuerstein G
    Am J Physiol; 1986 Jun; 250(6 Pt 2):H1093-101. PubMed ID: 3087219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyrotropin releasing hormone: autonomic effects upon cardiorespiratory function in endotoxic shock.
    Holaday JW; Faden AI
    Regul Pept; 1983 Oct; 7(2):111-25. PubMed ID: 6419292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shock.
    Bitterman H; Lefer AM
    Prostaglandins Leukot Essent Fatty Acids; 1988 May; 32(2):63-70. PubMed ID: 3406041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial action of a new opiate antagonist (Win 44,441-3) in hemorrhagic shock.
    Curtis MT; Lefer AM
    Eur J Pharmacol; 1982 Mar; 78(3):307-13. PubMed ID: 6279411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
    Bitterman H; Stahl GL; Lefer AM
    Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salutary effects of prostacyclin in endotoxic shock.
    Lefer AM; Tabas J; Smith EF
    Pharmacology; 1980; 21(3):206-12. PubMed ID: 6997895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of ethylketocyclazocine in hemorrhagic shock.
    Curtis MT; Lefer AM
    Adv Shock Res; 1983; 10():101-9. PubMed ID: 6308972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate.
    Asai H; Watanabe Y; Yamauchi-Kohno R; Doi O
    J Recept Signal Transduct Res; 2011 Dec; 31(6):416-22. PubMed ID: 22044177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial actions of nalorphine during hemorrhagic shock in cats.
    Hock CE; Curtis MT; Jaffe JS; Lefer AM
    Proc Soc Exp Biol Med; 1983 May; 173(1):76-81. PubMed ID: 6304745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacology of thyroliberin].
    Zakusov VV; Bulaev VM; Gan'shina TS; Kozhechkin SN; Mirzoian RS
    Biull Eksp Biol Med; 1983 Sep; 96(9):61-4. PubMed ID: 6412782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular mechanisms of thyrotropin-releasing hormone against experimental hemorrhagic shock.
    Zheng D; Chen HS; Hu DY
    Circ Shock; 1992 Mar; 36(3):169-73. PubMed ID: 1611701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
    Aoki N; Lefer AM
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Captopril and the intestinal response to hemorrhagic shock.
    Rosenfeld LM; Cooper HS
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):144-52. PubMed ID: 6758718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endorphins in shock and spinal injury; therapeutic effects of naloxone and thyrotropin-releasing hormone.
    Holaday JW
    Prog Clin Biol Res; 1983; 111():167-84. PubMed ID: 6306678
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in brain thyrotropin-releasing hormone in reversible and irreversible hemorrhagic shock in the rat.
    Mizobe T; Okuda C
    Circ Shock; 1988 Nov; 26(3):245-56. PubMed ID: 3145158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
    Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
    Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyrotropin releasing hormone improves blood pressure and survival in endotoxic shock.
    Holaday JW; Ruvio BA; Faden AI
    Eur J Pharmacol; 1981 Aug; 74(1):101-5. PubMed ID: 6797829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H; Smith BA; Lefer AM
    Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.